XML 51 R39.htm IDEA: XBRL DOCUMENT v3.8.0.1
Stock Option Plans (Details) - 2012 Plan [Member] - $ / shares
9 Months Ended
Sep. 30, 2017
Sep. 30, 2016
Oct. 13, 2017
Sep. 30, 2017
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]        
Shares available for grants (in shares) 2,894,000     7,558,000 [1]
Shares Available for Grant [Roll Forward]        
Beginning of the period (in shares) 2,894,000      
Increase to the 2012 Plan option pool (in shares) 6,000,000      
Options granted (in shares) (1,762,000)      
Options exercised (in shares) 0      
Options forfeited/cancelled (in shares) 426,000      
End of the period (in shares) [1] 7,558,000      
Number of Options Outstanding [Rollforward]        
Outstanding, beginning of the period (in shares) 6,958,000      
Increase to the 2012 Plan option pool (in shares) 0      
Options granted (in shares) 1,762,000      
Options exercised (in shares) (9,000)      
Options forfeited/cancelled (in shares) (606,000)      
Outstanding, end of the period (in shares) [1] 8,105,000      
Options exercisable, end of period (in shares) 4,072,000      
Number of RSUs Outstanding [Roll Forward]        
Outstanding, beginning of the period (in shares) 100,000      
Restricted stock units vested (in shares) (31,000)      
Outstanding, end of the period (in shares) [1] 69,000      
Weighted Average Exercise Price of Options [Rollforward]        
Outstanding, beginning of the period (in dollars per share) $ 3.60      
Increase to the 2012 Plan option pool (in dollars per share) 0      
Options granted (in dollars per share) 3.11      
Options exercised (in dollars per share) 2.66      
Options forfeited/cancelled (in dollars per share) 3.99      
Outstanding end of the period (in dollars per share) [1] 3.47      
Options exercisable, end of period (in dollars per share) $ 3.71      
Weighted-average assumptions [Abstract]        
Expected life 5 years 5 months 19 days 4 years 11 months 19 days    
Risk-free interest rates 1.78% 1.43%    
Volatility 59.04% 60.77%    
Dividend yield 0.00% 0.00%    
Maximum [Member]        
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]        
Common shares reserved for future issuance (in shares)       16,000,000
Maximum [Member] | Subsequent Event [Member]        
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]        
Shares available for grants (in shares)     2,500,000  
[1] On October 13, 2017, BioTime's Board of Directors (the "Board") determined to temporarily set a limit on shares available for grants for share-based awards pursuant to the 2012 Plan. While that limit remains in place, BioTime will not grant share-based awards for more than a total of approximately 2.5 million of the common shares remaining available for awards under the 2012 Plan.